Subscribe To
Entourage health announces timing of fiscal year end 2022 conference call for april 28
Company financials to be filed after market on April 27, 2023, and operational outlook to be provided during call, including milestones achieved Compa...
April 14, 2023, 7:35 am
Auxico resources reaches key milestone with environmental permit for minastyc project in colombia
Auxico Resources Canada Inc (CSE:AUAG, OTCQB:AUXIF) told investors the Environmental Impact Assessment (EIA) for its 100% controlled Minastyc propert...
April 12, 2023, 1:18 pm
Amryt pharma: final chance to pick up an attractive cvr
Amryt Pharma is being acquired at $14.50 per share and a contingent value right and is trading at $14.69. The contingent value right consists of 2 mil...
April 11, 2023, 7:56 am
Arway launches referral partner program as part of its business development efforts
ARway Corporation (CSE:ARWY, OTC:ARWYF) said it has launched its Referral Partner Program as part of its business development efforts, which will incr...
April 11, 2023, 7:40 am
Zymeworks: exciting short squeeze candidate with large cash holdings
Zymeworks has an enterprise value approaching zero, as milestone drug development payments were paid to...
April 10, 2023, 1:17 am
As ocuphire pharma rally gathers steam post-results, what did investors initially miss?
Clinical-stage ophthalmic biopharmaceutical company Ocuphire Pharma, Inc. (US:OCUP) announced its fourth-quarter and year-end financial results on Ma...
April 5, 2023, 10:28 pm
Abbvie lowers guidance after $150 million charge
Abbvie Inc. ABBV, +0.64% late Wednesday lowered its guidance for the year to include a charge of about $150 million. The pharma company said GAAP as w...
April 5, 2023, 5:21 pm
Illumina's (ilmn) novaseq x exceeds 200 order milestone
Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument....
April 5, 2023, 12:56 pm
Ubs chair highlights risk and reward of credit suisse deal
UBS's takeover of Credit Suisse was a “milestone” in global finance but entails a “huge amount of risk,” according to the bank's chair Colm Ke...
April 5, 2023, 7:57 am
Ubs chairman addresses shareholders on milestone credit suisse takeover
UBS's Chairman told the bank's annual shareholder meeting on Wednesday that the takeover of rival Credit Suisse was a significant...
April 5, 2023, 4:20 am
Southern's (so) vogtle 3 & 4 achieve power generation milestone
Southern Company's (SO) Vogtle units are an essential part of its commitment to delivering clean, safe, reliable and affordable energy to its customer...
April 4, 2023, 9:10 am
Here's a new million-dollar reason to buy crispr therapeutics
Vertex Pharmaceuticals is licensing CRISPR's technology for its type 1 diabetes program. The deal involves an up-front payment,...
April 1, 2023, 5:30 am
Deep medicine acquisition corp. and trugolf, inc. announce the execution of a definitive merger agreement
TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf s...
April 1, 2023, 2:03 am
Uber hits another milestone in healthcare, launching same-day prescription delivery
Uber Health is launching yet another initiative to increase access to care....
March 31, 2023, 11:16 pm
Milestone scientific inc. (mlss) q4 2022 earnings call transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q4 2022 Results Conference Call March 31, 2023 8:30 AM ET Company Participants David Waldman - Investor Relatio...
March 31, 2023, 7:34 pm
Scynexis: licensing deal with gsk, upgrading to a hold rating from a sell
GSK and SCYNEXIS signed an exclusive licensing agreement for Brexafemme, an FDA-approved medicine for vulvovaginal candidiasis. GSK will pay SCYNEXIS ...
March 31, 2023, 11:47 am
Shnata gold's first pour at singida a 'major milestone' says broker
Shanta Gold's first pour at the new Singida mine in Tanzania is a major milestone for the group, says h...
March 31, 2023, 11:46 am
Milestone scientific provides 2022 year-end business update
ROSELAND, N.J., March 31, 2023 (GLOBE NEWSWIRE) — milestone Scientific Inc. (NYSE: MLSS), a leading d...
March 31, 2023, 11:00 am
Sutro biopharma reports full year 2022 financial results, business highlights and select anticipated milestones
– Sutro plans to initiate a Phase 2/3 registration-directed study of luvelta for patients with platinum resistant ovarian cancer in the second quart...
March 30, 2023, 8:30 pm
Xeris biopharma announces research evaluation collaboration and option agreement with regeneron for xeriject
Xeris Biopharma Holdings (NASDAQ:XERS) told investors it has entered into a platform research evaluation collaboration and option agreement with Regen...
March 30, 2023, 11:31 am